(Q37452226)

20 August 2017

1 reference

title

Pralatrexate, a new hope for aggressive T-cell lymphomas? (English)

1 reference

20 August 2017

1 reference

Antonio Rueda

1

1 reference

20 August 2017

María Casanova

series ordinal

2

1 reference

20 August 2017

Cristina Quero

series ordinal

3

1 reference

20 August 2017

Angeles Medina-Pérez

series ordinal

4

1 reference

20 August 2017

1 April 2009

1 reference

Clinical and Translational Oncology

20 August 2017

1 reference

20 August 2017

11

1 reference

20 August 2017

4

1 reference

20 August 2017

215-220

1 reference

https://scigraph.springernature.com/pub.10.1007/s12094-009-0343-9

20 August 2017

0 references

cites work

Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-009-0343-9

Treatment of mature B-ALL and high grade B-NHL in children

21 January 2018

1 reference

12 December 2020

A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice

1 reference

12 December 2020

New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties

1 reference

12 December 2020

Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.

1 reference

12 December 2020

Recent advances in classical and non-classical antifolates as antitumor and antiopportunistic infection agents: Part II.

1 reference

12 December 2020

Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells

1 reference

12 December 2020

Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterin

1 reference

12 December 2020

Pralatrexate: an emerging new agent with activity in T-cell lymphomas

1 reference

12 December 2020

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

1 reference

12 December 2020

Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas

1 reference

12 December 2020

Edatrexate studies in non-small cell lung cancer

1 reference

12 December 2020

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

1 reference

12 December 2020

Molecular basis of antifolate resistance

1 reference

12 December 2020

Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project

1 reference

12 December 2020

The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma

1 reference

12 December 2020

Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells

1 reference

12 December 2020

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma

1 reference

12 December 2020

Treatment of T-cell non-Hodgkin's lymphoma.

1 reference

12 December 2020

Pralatrexate, a dihydrofolate reductase inhibitor for the potential treatment of several malignancies.

1 reference

12 December 2020

CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate

1 reference

12 December 2020

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.

1 reference

12 December 2020

Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).

1 reference

12 December 2020

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

1 reference

12 December 2020

Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

1 reference

12 December 2020

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate

1 reference

12 December 2020

10.1007/S12094-009-0343-9

Identifiers

DOI

1 reference

20 August 2017

1 reference